feed,title,long_url,short_url
InsiderMonkey,Jim Cramer Highlights The Change of Management in Kraft Heinz,https://insidermonkey.com/blog/--1671530,
InsiderMonkey,Jim Cramer Prefers Home Depot Over Fortune Brands as a Housing Play,https://insidermonkey.com/blog/--1671533,
InsiderMonkey,"Jim Cramer on SI-BONE: “This is a Great, Great Speculation”",https://insidermonkey.com/blog/--1671537,
InsiderMonkey,Piper Sandler and DA Davidson Have a Neutral View on Five9 (FIVN),https://insidermonkey.com/blog/--1671613,
InsiderMonkey,Jim Cramer on Fifth Third Bancorp: “I Think It’s a Buy”,https://insidermonkey.com/blog/--1671541,
InsiderMonkey,RBC Capital and Mizuho Securities Stay Bullish on Surgery Partners (SGRY),https://insidermonkey.com/blog/--1671617,
InsiderMonkey,Jim Cramer on USA Rare Earth: “I Can’t Bless It”,https://insidermonkey.com/blog/--1671546,
InsiderMonkey,Alvotech (ALVO) Secures $100 Million in New Financing,https://insidermonkey.com/blog/--1671620,
InsiderMonkey,Here’s What Analysts Think About Telix Pharmaceuticals (TLX),https://insidermonkey.com/blog/--1671625,
InsiderMonkey,Jim Cramer on Teradyne: “I Would Not Step Away From It”,https://insidermonkey.com/blog/--1671549,
InsiderMonkey,MARA Holdings (MARA) Faces Pressure After Bitcoin Drop,https://insidermonkey.com/blog/--1671627,
InsiderMonkey,Jim Cramer Says “Taiwan Semi Is a Very Good Company”,https://insidermonkey.com/blog/--1671552,
InsiderMonkey,Jim Cramer on Oracle: “I’m Not Really Sure About Their Business Model”,https://insidermonkey.com/blog/--1671561,
InsiderMonkey,UBS Gives Zai Lab (ZLAB) a Buy Rating,https://insidermonkey.com/blog/--1671629,
InsiderMonkey,Jim Cramer on Sweetgreen: “They’ve Got to Start Making Money”,https://insidermonkey.com/blog/--1671563,
InsiderMonkey,Soleno Therapeutics (SLNO) Among Stocks That Will Bounce Back According to Analysts,https://insidermonkey.com/blog/--1671631,
InsiderMonkey,Jim Cramer on Cheniere Energy: “It’s Not My Favorite Right Here”,https://insidermonkey.com/blog/--1671565,
InsiderMonkey,Price Targets Lowered on Corcept Therapeutics (CORT) After FDA Letter,https://insidermonkey.com/blog/--1671637,
InsiderMonkey,Analysts Lower Ultragenyx (RARE) Target but Stay Bullish,https://insidermonkey.com/blog/--1671665,
InsiderMonkey,Jim Cramer Says Amazon “Never Should Have Underperformed to Begin With”,https://insidermonkey.com/blog/--1671567,
